Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability.

Overview
Research
Identity
Additional Document Info
View All

authors

Nambiar, Anoop
LeBrasseur, Nathan
Limper, Andrew
Kritchevsky, Stephen
Musi, Nicolas
Tchkonia, Tamara
Kirkland, James
Kellogg, Dean
Justice, Jaime
Goros, Martin
Gelfond, Jonathan
Pascual, Rodolfo
Hashmi, Shahrukh
Masternak, Michal
Prata, Larissa

publication date

January 1, 2023

published in

EBioMedicine Journal

has subject area